Abstract
The chiral opioid analgesic tramadol was patented (1962) as a cis- and trans-racemates mixture. A first chiral switch led to the (±)-cis-(1RS,2RS) racemate, patented and approved as Tramal (1980), preferred over the (+)-cis-(1R,2R)-enantiomer. Consecutive chiral switches of (±)-cis-tramadol to (+)-cis-(1R,2R)-tramadol/salts were patented. This Viewpoint calls for developing (+)-cis-(1R,2R)-tramadol medicines and recognizing tramadol medicines as potential psychedelics to overcome the spreading tramadol crisis.
| Original language | English |
|---|---|
| Pages (from-to) | 1409-1416 |
| Number of pages | 8 |
| Journal | ACS Medicinal Chemistry Letters |
| Volume | 15 |
| Issue number | 9 |
| DOIs | |
| State | Published - 12 Sep 2024 |
Bibliographical note
Publisher Copyright:© 2024 American Chemical Society.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Analgesics
- Chiral Switch
- Opioid Crisis
- Patents
- Psychedelic
- Stereochemistry
- Tramadol
Fingerprint
Dive into the research topics of 'Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug─Past and Future'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver